Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1979-03-30
1980-11-18
Randolph, John D.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
544 91, A61K 3138, C07D49804
Patent
active
042345812
ABSTRACT:
2-Aminothiophene-3-carboxamides are converted to oxamates or fumaramides by acylation of the amino group. Cyclization yields thieno[2,3-d]pyrimidines which may also be prepared from the corresponding oxazines. Compounds illustrative of those having inhibitory action on the immediate hypersensitivity reaction in mammals are N-[3-(aminocarbonyl)-4,5,6,7-tetrahydrobenzo[b]thien-2-yl]oxamic acid, ethyl 5,6,7,8-tetrahydro-4-oxo-4H-benzothieno[2,3-d][1,3]oxazine-2-carboxylate, and ethyl 3,4-dihydro-6-ethyl-4-oxothieno[2,3-d]pyrimidine-2-carboxylate.
REFERENCES:
patent: 3953468 (1976-04-01), Wechter et al.
patent: 3966965 (1976-06-01), Sellstedt et al.
patent: 4054656 (1977-10-01), Temple, Jr.
patent: 4159377 (1979-06-01), Temple, Jr.
Fitton et al., J. Chem. Soc. (6), 1971, pp. 146 to 149.
Shvedov et al., Chem. Abstracts, vol. 66, abst. 37,711w (1967).
Nakanishi et al., Chem. Abst. vol. 78, abst. 29795j (1973) (abst. of Jap. Pat. 73-42,271).
Lorente et al., Chem. Abst. vol. 83, abst. 178980w (1975).
Temple et al., J. Med. Chem., vol. 22, No. 5, pp. 505 to 510, (1979).
Carnahan Robert E.
Mead Johnson & Company
Randolph John D.
Uloth Robert H.
LandOfFree
Thieno[2,3-d]oxazines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thieno[2,3-d]oxazines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thieno[2,3-d]oxazines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-597944